Medtronic Loses Another Jury Trial Over Stent Patents
Fresh off its loss against rival Guidant in a patent dispute over drug-coated stents, medical device maker Medtronic said Monday it has lost another dispute against Johnson & Johnson Inc.'s Cordis...To view the full article, register now.
Already a subscriber? Click here to view full article